Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

Peer Review reports

Original Submission
21 Nov 2021	Submitted	Original manuscript
14 Mar 2022	Reviewed	Reviewer Report - Monica Badve
17 Mar 2022	Reviewed	Reviewer Report - Cheney Drew
5 Apr 2022	Author responded	Author comments - Jae-Yong Nam
Resubmission - Version 2
5 Apr 2022	Submitted	Manuscript version 2
17 Apr 2022	Reviewed	Reviewer Report - Monica Badve
21 Apr 2022	Reviewed	Reviewer Report - Cheney Drew
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
23 Apr 2022	Editorially accepted
18 May 2022	Article published	10.1186/s13063-022-06327-4

Back to article page